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Abstract
Background: Fifty thousand knee replacements are performed annually in the UK at an estimated
cost of £150 million. Post-operative improvement depends on a number of factors including
implant design and patient associated factors. To our knowledge there are no published study's
comparing the results of AP glide and rotating platform designs of LCS knee arthroplasty.
Therefore we feel that a study is required to investigate and compare the effects of two types of
LCS total knee arthroplasty on joint proprioception and range of motion.
Methods/Design: Patients will be randomised to receive either a LCS AP glide or Rotating
platform prosthesis. Clinical scores (Oxford knee score, American knee society score, EuroQol),
range of motion and proprioception will be assessed prior to and at 3,6, 12 and 24 months after
the operation. Proprioception will be assessed in terms of absolute error angle (mean difference
between the target angle and the response angle). Knee angles will be measured in degrees using
an electromagnetic tracking device, Polhemus 3Space Fastrak that detects positions of sensors
placed on the test limb. Student's t-test will be used to compare the mean of two groups.
Discussion: Evidence is lacking concerning the best prosthesis to use for patients undergoing total
knee replacement. This pragmatic randomised trial will test the null hypothesis that
anteroposterior glide LCS knee arthroplasty does not result in better post operative knee motion
and proprioception as compared to rotating platform LCS knee.
Trial Registration: ISRCTN52943804
Background
Total knee replacement surgery is one of the commoner
types of replacement surgeries performed nowadays with
about 50,000 knee replacements being performed annually
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in the UK. Fixed bearing total knee arthroplasty (TKA) has
been used as a standard treatment for osteoarthritis of the
knee joint. It allows fairly unconstrained motion of the
knee joint. Flexion and extension of the knee involve
antero-posterior gliding, rotation and femoral rollback,
which are not reproduced in fixed bearing TKA.
The LCS (low contact stress) rotating platform TKA system
attempts as near-normal reproduction of knee motion as
possible, minimising interface stresses by allowing rotation
(with this design, the posterior cruciate ligament has to be
sacrificed). The AP (antero-posterior) glide LCS type allows
both antero-posterior glide and rotation. With this design,
the posterior cruciate ligament needs to be intact to allow
normal femoral rollback. Rather than imposing a predeter-
mined pattern of motion, the AP glide design permits bear-
ing movement, which corresponds to the requirements of
individual patient anatomy. We hypothesise that these fea-
tures of the AP glide TKA may allow improved joint posi-
tion sense (proprioception) and better overall functional
outcome.
The LCS rotating platform design has good clinical results,
but, as results improve in terms of flexion and long term
survival, more subtle measures of the return to near normal
post-operative function become important. Proprioception
is affected by osteoarthritis of the knee joint [1]. As propri-
oception is one of the protective mechanisms of a joint, one
should aim to preserve or enhance it. Proprioceptive func-
tion after TKA is debated, with studies reporting conflicting
results [2-4]. Post-operative improvement depends on a
number of factors, including implant design and patient-
associated factors. To our knowledge, there are no pub-
lished studies comparing the results of AP glide and rotat-
ing platform TKA.
Methods/Design
Null Hypothesis
Antero-posterior glide LCS knee arthroplasty does not
result in better post-operative knee motion and propriocep-
tion as compared to rotating platform LCS knee arthro-
plasty.
Objectives
The trial proposes to:
1. Study the improvement in knee motion and overall func-
tion after AP glide and rotating platform design LCS TKA.
2. Examine the effect of this intervention on propriocep-
tion.
Trial Summary
This study aims to compare the post operative knee motion
and proprioception after LCS AP glide and rotating plat-
form knee replacement designs. We propose to recruit a
total of 50 patients (25 in each group) in the trial. The
patients will be recruited from the pre-operative assessment
clinic following their informed consent to take part in the
study. Randomisation will take place at the time of surgery.
The primary outcome measure will be the knee motion and
prorioception. The secondary outcomes will include the
Oxford Knee Score [5], American Knee Society Score [6],
EuroQol EQ-5D [7], and post-operative complications. All
outcomes will be evaluated at 3, 6, 12 and 24 months after
the index surgery.
Study type
A randomised controlled trial comparing the effects of AP
glide and rotating platform design LCS TKA.
Participants
Participants will be patients undergoing primary bi- (tibio-
femoral joint) or tri- (tibio-femoral-patellar joint) compart-
mental knee arthroplasty. Patients will be recruited from
the Orthopaedic Pre-operative clinics held at the Orthopae-
dic Outpatient Department of the City General Hospital,
Stoke on Trent, England.
Treatment details
All surgical procedures will be performed in the operating
theatres of the City General Hospital, Stoke on Trent, Eng-
land. In the operating theatre, patients will be randomised
to receive one of the two types of prosthesis using a stand-
ard surgical technique.
Eligibility
Patient will be included if:
1. They require a primary bi- or tri-compartmental knee
replacement.
2. They have given their voluntary, written informed con-
sent.
Patients will be excluded if:
1. They are going to have revision knee surgery.
2. They are scheduled to have bilateral knee replacement in
one sitting.
3. They suffer from rheumatoid arthritis, diabetes mellitus,
posttraumatic arthritis or any form of neurological disor-
der, which can affect the joint position sense.
4. They have had or will require a major knee arthrotomy
on the other same side within 6 months period.BMC Musculoskeletal Disorders 2007, 8:87 http://www.biomedcentral.com/1471-2474/8/87
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5. They have more than 20° of varus, valgus or flexion
deformity
Recruitment
Patients will be recruited from the orthopaedic pre-opera-
tive assessment clinic. Their medical notes will be screened
to assess suitability. At the pre-operative visit, patients will
be informed of the nature of the study by their consultant
orthopaedic surgeon. Eligible patients will be provided
with an information leaflet explaining the nature of the
study. They would be invited to ask questions regarding the
study. They will then be given the opportunity to think
about whether they would like to participate or not. During
this period, they will be contacted by the research nurse to
discuss their participation and to answer any questions they
may have. On the day of the admission, the patients will
have a further opportunity to discuss the participation in
the trial. Patients willing to take part in this trial will be then
invited to sign a consent form by a member of the research
team with the approval of the operating consultant. Base-
line data will be acquired on admission. Once patients have
consented for the study, they will then be randomised in
the operating theatre.
Randomisation
Patients will be randomised using a minimisation pro-
gramme called Minim [8]. On arrival in the operating suite,
eligibility criteria for each patient will be re-checked. Ran-
domisation will take place once the knee replacement sur-
gery is started and it is decided that either of these two TKA
designs could be used. The patient will be allotted a group,
i.e. AP glide knee replacement or rotating platform knee
replacement. Provision will be made for an easy access to
the randomisation service on the operating theatre compu-
ter. The patients in both groups will have post-operative
rehabilitation regime as prescribed by the operating sur-
geon. Any complication during or after the operation will
be noted. Patients will then be seen at their post operative
visit at 3, 6, 12 and 24 months where knee score forms will
be completed, proprioception will be evaluated and range
of joint movement will be quantified using the FASTRACK
system (Polhemus Fastrack 3Space Manual, Polhemus Inc,
Colchester, VT, 1992).
Assesment of outcome
All the assessment procedure will be performed in the Bion-
ics Laboratory, City General Hospital, Stoke on Trent, Eng-
land.
Primary outcome
The primary outcome measure for this study will be the
improvement in knee motion (as measured by FASTRAK
system). This will be done before operation and at 3, 6, 12
and 24 months after the operation. Fastrak has been devel-
oped by Polhemus (Colchester, VT, USA) in the early 1990
to monitor aircraft pilots and to be used in the animation
industry. FASTRAK is a 3 dimensional tracking device based
on emission of a low frequency magnetic field by a trans-
mitter. Within this magnetic field, the position and orienta-
tion of up to four sensors and their spatial relationship can
be recorded simultaneously. FASTRAK provides dynamic,
real-time six degrees of freedom measurement. It computes
the position (X, Y, Z Cartesian coordinates) and orientation
(azimuth, elevation and roll) of the sensor through space
relative to the source transmitter. Each sensor measures
data in three different planes: a primary plane of movement
and two secondary planes. The recording is performed dig-
itally on a computer. The data can be represented as a real
time graph or numerically as range of movement. To per-
form each Fastrak assessment, double-sided adhesive discs
will be used to fix all sensors to the skin. The first sensor will
be placed just above the lateral malleolus. The second sen-
sor will be placed just lateral to the the anterior tibial tuber-
osity of the tibia. The third sensor will be placed over the
lateral condyle of the femur. The wires connecting the sen-
sors to the transmitter were secured with Micropore surgical
tape (3M Healthcare Ltd. Loughborough, Leicestershire,
UK) to avoid pull on the sensors.
Three flexion and extension movements will be performed
consecutively without stopping so as to obtain three meas-
urements. The Fastrak will be centred at 0° at full knee
extension before movements begin. Each patient will per-
form a trial run to confirm that the patient satisfactorily
understood the instructions. The average range of motion
of the three trials will be used for analysis. A preliminary
feasibility study showed a variability of 3° ± 1° in the meas-
urements of range of flexion and extension of the knee per-
formed using the Fastrak system in 25 patients on the
waiting list for total knee arthroplasty. All measurements
will be taken by the same researcher (AR) who is not
involved in the clinical management of the patients.
Secondary outcomes
1. Proprioception, as measured by absolute error angle, i.e.
the difference between actual and perceived angle through
which the joint has been moved passively, will be meas-
ured using the Fastrak apparatus (Polhemus, Colchester,
VT, USA). Briefly, each subject will have their knee screened
from view while sitting on an examination couch with the
knees hanging from the side. Each knee will be moved pas-
sively to one of three predetermined position (full exten-
sion, 30° and 60° of flexion), and held in that position for
5 seconds. The limb will then returned to a resting position.
The patient is then asked to reproduce the knee position to
which it had been moved passively. The test will be
repeated three times per each of three positions.BMC Musculoskeletal Disorders 2007, 8:87 http://www.biomedcentral.com/1471-2474/8/87
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2. The American Knee Society Score [6], Oxford Knee Score
[5], and EuroQol EQ-5D [7] will be recorded pre-opera-
tively and at 3,6,12 and 24 months after the operation.
3. Complications.
Statistical considerations
Sample size
The sample size of the trial has been calculated on the basis
of a pilot study. Range of motion of the knee joint is the pri-
mary outcome in our study. We found that the standard
deviation for this parameter in the pilot study was 20°. The
anticipated difference between the mean (which we think
would be of clinical significance) was considered as 20°.
The sample size required for an alpha of 0.05 and a power
of 90% was found to be 22 cases per group. To allow for
dropouts, recruitment a total of 25 patients in each group
of the study would be a reasonable option.
Analysis
t test will be used to compare variables between the groups
where the data are approximately normally distributed,
possibly after transformation. Non-normal data will be
assessed using the Mann-Whitney test. Any imbalances
between the groups at baseline will be adjusted for by using
ANCOVA. Analysis will be performed using the intention
to treat criterion.
Blinding
The laboratory personnel will be blinded to the treatment
allocation, and will perform knee motion and propriocep-
tive assessments. The research nurse, who will be blinded to
the treatment allocation, will perform the knee scoring of
both groups.
Data collection
The data will be collected from the medical records during
the in hospital stay of the patients. Final data collection will
take place at the post-operative visit at 24 months. The last
observation will be carried forward for data analysis.
Protocol deviations
Any changes to the protocol will be recorded. Any amend-
ments that may be required once the trial has started will be
submitted for approval by the ethics committee.
Informed consent
All eligible patients who agree to take part will sign an
informed consent form. They will confirm that they have
been given the information that they require, and that the
study has been explained to them.
Confidentiality
Only the trial organisers/administrators will have access to
patients' notes and questionnaires. All recorded informa-
tion will be stored separately from patients' names and
addresses.
Ethics
The trial has been given ethics permission by our Local Eth-
ics Committee, and is registered as ISRCTN 52943804.
Discussion
Evidence is lacking concerning the best prosthesis to use for
patients undergoing total knee replacement. This pragmatic
randomised trial will test the null hypothesis that antero-
posterior glide LCS knee arthroplasty does not result in bet-
ter post-operative knee motion and proprioception as
compared to rotating platform LCS knee.
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